Successful treatment of adult multisystemic langerhans cell histiocytosis with psoralen-UV-A, prednisolone, mercaptopurine, and vinblastine

Archives of Dermatology

Volumn 144, Issue 5, 2008, Pages 649-653

  Von Stebut, Esther ^a   Schadmand Fischer, Simin ^a   Bräuninger, Wolfgang ^a   Kreft, Andreas ^a   Doberauer, Claus ^b   Steinbrink, Kerstin ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Evangelische Kliniken Gelsenkirchen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; DESMOPRESSIN ACETATE; MERCAPTOPURINE; METHYLPREDNISOLONE ACEPONATE; METOCLOPRAMIDE; PREDNISOLONE; PREDNISONE; PSORALEN; VINBLASTINE; ZOLEDRONIC ACID;

AGED; ARTICLE; BONE NECROSIS; CASE REPORT; DIABETES INSIPIDUS; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; LANGERHANS CELL HISTIOCYTOSIS; MULTIPLE CYCLE TREATMENT; NAUSEA; PHOTOTHERAPY; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; UNSPECIFIED SIDE EFFECT;

AGED; BONE MARROW; DRUG THERAPY, COMBINATION; FEMALE; FICUSIN; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; PHOTOSENSITIZING AGENTS; PITUITARY GLAND; PREDNISOLONE; SKIN; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VINBLASTINE;

EID: 44249119590     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.5.649     Document Type: Article

References (27)

1. Leonidas JC, Guelfguat M, Valderrama E. Langerhans' cell histiocytosis. Lancet. 2003;361(9365):1293-1295.
2. Laman JD, Leenen PJ, Annels NE, Hogedoorn PC, Egeler RM. Langerhans-cell histiocytosis "insight into DC biology." Trends Immunol. 2003;24(4):190-196.
3. Howarth DM, Gilchrist GS, Mullan BP, Wisemann GA, Edmonson JH, Schomerg PJ. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer. 1999;85(10):2278-2290.
4. Aricò M. Langerhans cell histiocytosis: more questions than answers? Eur J Cancer. 2004;40(10):1467-1473.
5. Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. Eur J Haematol. 2006;76(5):363-368.
6. Lichtenstein L. Histiocytosis X integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schüler-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol. 1953;56(1):84-102.
7. Favara BE, Feller AC, Pauli M, et al; WHO Committee on Histiocyte/Reticulum Cell Proliferations; Reclassification Working Group of the Histiocytosis Society. Contemporary classification of histiocyte disorders. Med Pediatr Oncol. 1997;29(3):157-166.
8. Vassallo R, Ryu JH, Colby TV, Hartmenn T, Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000;342(26):1969-1978.
9. Ladisch S, Gadner H, Aricó M, et al; Histiocyte Society. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23(2):107-110.
10. Gadner H, Grois N, Aricò M, et al; Histiocyte Society. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis [published correction appears in J Pediatr. 2001;139(1):170]. J Pediatr. 2001;138(5):728-734.
11. Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H; DAL-HX Study Group. Treatment of multisystem Langerhans cell histiocytosis: results of the DAL-HX 83 and DAL-HX 90 studies. Klin Padiatr. 2000;212(4):139-144.
12. Aricò M, Girschikofky M, Généreau T, et al. Langerhans cell histiocytosis in adults: report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003;39(16):2341-2348.
13. Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12(2):327-338.
14. Seegenschmiedt HM, Micke O, Olschewski T, et al. Radiotherapy is effective in symptomatic Langerhans cell histiocytosis: long-term results of a multicenter study in 63 patients [abstract]. Int J Radiat Oncol Biol Phys. 2003;57(suppl 2):S251.
15. Greinix HT, Storb R, Sanders JE, Petersen FB. Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis. Bone Marrow Transplant. 1992;10(1):39-44.
16. Tsele E, Thomas DM, Chu AC. Treatment of adult Langerhans cell histiocytosis with etoposide. J Am Acad Dermatol. 1992;27(1):61-64.
17. Giona F, Caruso R, Testi AM, et al. Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institution. Cancer. 1997;80(9):1786-1791.
18. Saven A, Burian C. Cladribine activity in adult Langerhans-cell histiocytosis. Blood. 1999;93(12):4125-4130.
19. Minkov M, Grois N, Heitger A, Pötschger U, Westermeier T, Gadner H; DAL-HX Study Group. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol. 2002;39(6):581-585.
20. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathological study of 48 cases. Am J Surg Pathol. 1993;17(10):971-986.
21. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans cell histiocytosis in adults. N Engl J Med. 2002;346(7):484-490.
22. Steiner M, Matthes-Martin S, Attarbaschi A, et al. Improved outcome of treatment-resistant high-risk Langerhans'-cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning. Bone Marrow Transplant. 2005;36(3):215-225.
23. Kelly KM, Beverley PC, Chu AC, et al. Successful in vivo immunolocalization of Langerhans cells with the use of a monoclonal antibody, NA1/34. J Pediatr. 1994;125(5, pt 1):717-722.
24. Montella L, Insabato L, Palmieri G. Imatinib mesylate for cerebral Langerhans'-cell histiocytosis. N Engl J Med. 2004;351(10):1034-1035.
25. Misery L, Larbre B, Lyonnet S, Faure M, Thivolet J. Remission of Langerhans cell histiocytosis with thalidomide treatment. Clin Exp Dermatol. 1993;18(5):487.
26. Mauro E, Fraulini C, Rigolin GM, Galeotii R, Spanedda R, Castoldi G. A case of disseminated Langerhans cell histiocytosis treated with thalidomide. Eur J Haematol. 2005;74(2):172-174.
27. Jordan MB, McClain KL, Yan X, Hicks J, Jaffe R. Anti-CD52 antibody, alemtuzumab, binds to Langerhans cells in Langerhans cell histiocytosis. Pediatr Blood Cancer. 2005;44(3):251-254.